Bridge Pharmaceuticals Raises $35M
San Francisco-based Bridge Pharmaceuticals has raised $35M in a Series B round, the firm said today. The funding came from existing investors along with Granite Gobal Ventures. Helen Wong of Granite Global has joined the firm's board of directors. Bridge Pharmaceuticals provides contract research operations for pharmaceutical firms, with operations in Gaithersburg, Maryland and Beijing, China. The firm is a spinoff of SRI.
posted on Tuesday, February 13, 2007 (Link to more information)
Related companies:
Bridge 37 Ventures
Related stories:
> MicuRx Raises $10M
> Third Rock Ventures Raises $426M Fund, Sets Up Shop In San Francisco
> MAP Pharmaceuticals Raises $50M
> TransOral Pharmaceuticals Raises $40M
> Anthera Pharmaceuticals Raises $36M
silicontap.com Home